Overview of ASEAN healthcare market

Appendix 1: Overview of ASEAN healthcare market

Exhibit 118: ASEAN forms c.5% of world population...

Exhibit 119: ...c.3% of world GDP...

70% 20013-20 CAGR

2004-13 CAGR

20013-20 CAGR

2004-13 CAGR

2020E ASEAN-4

Rest of World

ASEAN-4

Rest of World

Source: Euromonitor, Goldman Sachs Global Investment Research.

Source: Euromonitor, Goldman Sachs Global Investment Research.

Exhibit 120: ...but only c.1% of world healthcare spending Exhibit 121: Healthcare expenditure as % of GDP of ASEAN countries is among the lowest globally (2013)

Healthcare spending

Healthcare expenditure as % of GDP

2004-13 CAGR

20013-20 CAGR

u rope s tr

Rest of World

out S

Source: Euromonitor, Goldman Sachs Global Investment Research.

Source: Euromonitor.

Exhibit 122: ASEAN-4 HC spending showed

Exhibit 124: …rising needs and affordability for strong growth at 1.2X of GDP growth and…

Exhibit 123: …2X its global market share in the

last decade; this is driven by….

better healthcare from individuals…

ASEAN-4 Global HC market share

US$bn 2004-13 CAGR

Singapore Thailand Indonesia Malaysia

Singapore: 15.2%

ASEAN-4 HC expenditure % GDP - RHS

Obesity/overweight as %

60 Indonesia : 17.9% ASEAN-4 : 14.3%

R-square with HC % GDP

Median age (yrs)

R-square with HC % GDP

GDP per capita (US$)

73% 27% 9% Source: Euromonitor.

Singapore Malaysia

R-square with HC % GDP

Source: Euromonitor.

Source: Euromonitor.

Exhibit 127: Outlook is bright as HC expenditure though lagging private spending, and…

Exhibit 125: …decent government support,

Exhibit 126: …from robust medical tourism

spending trends during this period

as % of GDP still low relative to other countries (2013)

Public HC exp % Total

Public HC exp % Total

Medical tourism as % private HC spending - RHS

OECD average 13.1%

and world average 10.5%

Thailand 4.3% Singapore 5.2% and Indonesia 3.5% and

ta n co b ia n bl ic liz e ia d go ru ent n ta Fi nes ville nei ra in

lA idad n

Source: Euromonitor.

Source: Frost & Sullivan.

Source: Euromonitor.

Exhibit 128: ASEAN hospitals generally show

Exhibit 130: ….achieved by growing beds, solid DACF growth over 2009-2013 due to….

Exhibit 129: …strong gains in revenue market

share especially in Thailand, which was…

increasing market share and price increases

25% DACF CAGR

EBITDA CAGR

Bangkok Dusit 2013 Bumrungrad Raffles Medical Bangkok Chain KPJ

Singapore Malaysia Thailand

Source: Company data.

Source: Company data, Euromonitor.

Source: Company data, MOH Malaysia, MOPH Thailand, MOH Indonesia, MOH Singapore.

Exhibit 133: …this depressed asset turns / similar to US, but less leverage/higher growth

Exhibit 131: ASEAN hospitals have high CROCI,

Exhibit 132: CROCI did decline for some hospitals

as new capacity takes time to be utilized and…

EBITDA margins

20% USA ASEAN South Africa

Tax Burden 18%

Asset turns

EBITDA margins - RHS 17%

CROCI (%)

DACF/(EBITDA - taxes)

Bangkok Dusit

Bangkok Chain

KPJ 0.6X 12% 12% 10% 8% 6%

Source: Company data, Bloomberg.

Source: Company data.

Source: Company data.

Exhibit 134: Healthcare spending to grow 1.5X

Exhibit 136: Private to outgrow public, as we GDP by 2020E (1.2X in past 10 years) as Indo hits

Exhibit 135: ASEAN-4 global HC market share

expect govt. funding to be increasingly stressed more sweet spots

and HC expenditure as % of GDP to continue to

rise

Public HC exp % Total 180

US$ bn 2014-20E CAGR

ASEAN-4 Global HC market share

Private HC exp % Total

Singapore: 9.4%

ASEAN-4 HC expenditure % GDP - RHS

Thailand: 9.0% Indonesia: 16.6%

Singapore 3.5% Malaysia Thailand Indonesia

2017E 2018E 2019E 2020E

Source: Euromonitor, Goldman Sachs Global Investment Research.

Source: Euromonitor, Goldman Sachs Global Investment Research.

Source: Euromonitor, Goldman Sachs Global Investment Research.

Exhibit 137: Rising contribution from China/LCMV

Exhibit 139: …given the roadmap of beds tourists a driver for private HC expenditure

Exhibit 138: GS-covered Indo hospitals’ revenues

mkt. share to gain most, followed by TH/MY/SG

additions ahead, and not including M&A